Novo Nordisk N1VO34 Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Assets	218.93B	242.84B	241.26B	250.03B	280.75B	300.1B	314.49B	298.92B
Total Current Assets	102.98B	119.48B	108.19B	113.94B	137.55B	142.2B	139.65B	116.42B
Cash and Equivalents	22.76B	28.47B	12.65B	14.94B	21.57B	30.14B	14.39B	6.32B
Total Non-Current Assets	175.51B	187B	199.73B	206.1B	218.23B	239.36B	265.8B	280.73B
Total Liabilities	144.48B	166.16B	157.77B	170.15B	190.28B	207.11B	207.93B	200.01B
Total Current Liabilities	109.66B	130.26B	120.94B	131.96B	156.62B	172.55B	169.66B	165.61B
Total Non-Current Liabilities	59B	60.04B	61.15B	62.46B	53.08B	54.48B	58.8B	51.17B
Common Equity	456M	456M	456M	456M	451M	451M	451M	451M
Retained Earnings	73.17B	73.67B	80.59B	77.07B	88.12B	91.74B	104.84B	99.05B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Total Assets	97.54B	102.36B	110.77B	125.61B	144.92B	194.51B	241.26B	314.49B
Total Current Assets	59.77B	60.08B	59.07B	62.46B	65.81B	85.6B	108.19B	139.65B
Cash and Equivalents	18.69B	18.85B	15.64B	15.48B	12.76B	10.72B	12.2B	14.39B
Total Non-Current Assets	45.27B	49.82B	51.84B	57.59B	63.33B	70.75B	83.49B	106.56B
Total Liabilities	52.27B	52.54B	58.93B	68.02B	81.6B	123.76B	157.77B	207.93B
Total Current Liabilities	47.44B	47.06B	54.16B	58.98B	70.27B	99.52B	120.94B	169.66B
Total Non-Current Liabilities	4.83B	5.48B	4.77B	12.05B	14.22B	37.21B	61.15B	58.8B
Total Equity	45.27B	49.82B	51.84B	57.59B	63.33B	70.75B	83.49B	106.56B
Common Equity	510M	500M	490M	480M	470M	462M	456M	451M
Retained Earnings	46.11B	48.98B	53.41B	57.82B	63.77B	72B	80.59B	104.84B